Chinese biotechs cited by name in the BIOSECURE Act saw their stocks grow after a setback that left the bill’s future up in ...
A new study from scientists at VIB-KU Leuven Center for Brain & Disease and elsewhere reveals the role of an RNA binding protein called Fused in Sarcoma (FUS) in the development of frontotemporal ...
Such details emerged from a new study by researchers at Memorial Sloan Kettering Cancer Center (MSK). They found that in ...
Researchers suggest dual antibody-drug–loaded nanotherapeutics can emerge as an attractive platform to improve outcomes with ...
An MIT-based team developed a technique to create high-quality images of human brains from the gross morphological level to ...
Antimicrobial resistance is a huge problem due to a weak pipeline of new available treatments and endemic resistance to ...
The new facility will house three modular trains manufacturing organic acids for the concrete, cleaning, agricultural, and ...
Syntis Bio launches with oral therapy platform to treat obesity, diabetes, and rare diseases by unlocking the therapeutic ...
Alzheon says it expects to fund the completion of a pivotal Phase III trial and regulatory filings later this year for its ...
Researchers are angered by the latest update to Google DeepMind’s renowned protein structure prediction algorithm, which ...
The engineered cell's ability to reorganize itself in response to environmental signals mimics biological cells' response to ...
Moleculent, a company pioneering technology to study the communication between cells in human tissue, announced $26 million ...